Christopher J. Kelly
Portsmouth
Summary
Demonstrated leadership in patient conversions and achieved 43% sales growth through strategic initiatives in oncology and hematology. Expertise in enhancing patient access to therapies and optimizing market strategies across complex healthcare environments.
Overview
23
23
years of professional experience
Work History
Senior Territory Manager
NOVOCURE
Portsmouth
05.2024 - Current
- Led the nation in patient conversions based on targeted support programs.
- Secured 43% growth in volume through strategic initiatives.
- Drove utilization of OPTUNE GIO, an NCCN Category 1 preferred therapy in glioblastoma and NSCLC, enhancing patient access.
- Partnered cross-functionally with intake, reimbursement, field support, and care coordinators to efficiently process and pull through prescriptions.
- Consulted with key prescribers to determine optimal therapy start times, maximizing patient duration on therapy.
- Certified HCPs for prescribing and interacted with patients to provide information sessions.
- Field conduit with Novocure’s Health Policy team working to gain MD support for state Medicaid coverage initiatives.
- Focused on therapeutic areas such as glioblastoma, NSCLC, and locally advanced pancreatic cancer.
Associate Director/Oncology Account Manager
Bristol Myers Squibb (formerly Mirati Therapeutics)
San Diego
07.2022 - 05.2024
- Contributed to launch of KRAZATI (adagrasib) for KRAS G12-C driven NSCLC, facilitating successful market entry.
- 400% sales growth 2023 to 2024 and 100% volume growth Q1 2024 (#1 in Northeast)
- Established reimbursement touchpoints to enhance patient financial access and streamline support processes.
- Collaborate with specialty pharmacy, IDN and aggregator buying participants with in-office dispensing.
Uro-Oncology Account Manager
Sumitomo Pharma (formerly Myovant Sciences)
Brisbane
10.2020 - 07.2022
- Inaugural sales team member for the launch of ORGOVYX (relugolix) in advanced prostate cancer.
- Managed prescription fulfillment through specialty pharmacy distribution and in-office dispensing to ensure patient access.
- Acted as Market Access Liaison for the commercial division, training the organization on payer analytics tools to enhance market strategy.
Key Account Director-Hematology
Verastem Oncology
Needham
01.2020 - 10.2020
- Developed strategic account plans to establish Copiktra (duvelisib) in academic centers in Northeast.
- Partnered with market access colleagues to support payer initiatives, facilitating improved access strategies.
- Collaborated with marketing and compliance to develop virtual access tools on VEEVA platform, enhancing accessibility.
- 116% to quota 1H 2020 and trending 120% to goal Q3 prior to acquisition.
- (Secura Biosciences acquisition 10/2020)
Hematology/Oncology Sales Consultant
Bayer Healthcare
Whippany
05.2018 - 01.2020
- Launched Vitrakvi (larotrectinib) for NTRK fusion positive solid tumors, enhancing treatment options for lung, brain, sarcomas, and ovarian cancers
- Managed Aliqopa launch and sales strategy for follicular lymphoma treatment
- Stivarga (regorafenib) tablets and (copanlisib) IV for colorectal.
- Consistently achieved high performance and territory growth (ex: Q1 2019 national ranking:3)
- Multiple MBO awards for leadership, cross functional teamwork, and collaboration.
- Interacted with cross functional business units on advisory boards and field marketing projects including market research.
Executive Immunotherapy Sales Specialist
AstraZeneca
Wilmington
09.2017 - 05.2018
- Launched Fasenra (benralizumab) subcutaneous IgG1 monoclonal antibody, enhancing treatment options for patients with eosinophilic mediated diseases.
Oncology Sales Consultant-Solid Tumor Franchise
Bayer Healthcare
Whippany
04.2015 - 09.2017
- Guided accounts in securing state licensing for Xofigo (radium 223) to enhance access for prostate cancer patients.
- Sold oral kinase inhibitors Stivarga (regorafinib) and Nexavar (sorafenib) for colorectal, GIST, HCC, and RCC, contributing to expanded treatment options.
- Developed new pathways to patient treatment between urology, oncology, and radiation oncology/nuclear medicine.
- Facilitated reimbursement and patient access, optimizing buy and bill processes for improved treatment delivery.
- 2016: 66% NRX growth (#4 overall) and 110% unit growth (#2 overall)
Specialty Sales Consultant-Neurology/Orphan Disease
Jazz Pharmaceuticals
Palo Alto
01.2007 - 01.2015
- Regional Sales Trainer 2013-2015
- Promoted and sold Xyrem (CIII) and Prialt (ziconotide) to healthcare providers, enhancing pain management options.
- Facilitated access to Xyrem for mid-level prescribers in NH by coordinating with Jazz Commercial Operations.
- Executed launch strategy for Luvox CR (fluvoxamine maleate) in 2008.
- - Neurology
Breast Care Specialist-Tumor Diagnostics
Johnson & Johnson, Ethicon Endo-Surgery Oncology
New Brunswick
01.2003 - 01.2007
- Trained surgeons on biopsy options across various imaging modalities, enhancing breast cancer detection capabilities.
- Negotiated capital and consumable sales terms at CEO/CFO level, fostering strong relationships and driving growth.
- Implemented collaborative sales strategies with United Medical Systems, GE, and Medtronic, expanding market reach.
- Recognized as Sales Leader in 2005 for outstanding performance.
Education
Bachelor of Arts - Communications
Bridgewater State University
Bridgewater, MAMaster of Business Administration -
Southern New Hampshire University
Manchester, NHSkills
Medical device sales
- Account management
- Market access support
- Buy and bill
- Contract management
- Specialty pharmacy
- Patient support services
- Hematology
- Rare Disease
- Cross-functional experience
- Cross-functional teamwork
Websites
Personal Information
Title: Senior Territory Manager
Timeline
Senior Territory Manager
NOVOCURE
05.2024 - Current
Associate Director/Oncology Account Manager
Bristol Myers Squibb (formerly Mirati Therapeutics)
07.2022 - 05.2024
Uro-Oncology Account Manager
Sumitomo Pharma (formerly Myovant Sciences)
10.2020 - 07.2022
Key Account Director-Hematology
Verastem Oncology
01.2020 - 10.2020
Hematology/Oncology Sales Consultant
Bayer Healthcare
05.2018 - 01.2020
Executive Immunotherapy Sales Specialist
AstraZeneca
09.2017 - 05.2018
Oncology Sales Consultant-Solid Tumor Franchise
Bayer Healthcare
04.2015 - 09.2017
Specialty Sales Consultant-Neurology/Orphan Disease
Jazz Pharmaceuticals
01.2007 - 01.2015
Breast Care Specialist-Tumor Diagnostics
Johnson & Johnson, Ethicon Endo-Surgery Oncology
01.2003 - 01.2007
Bachelor of Arts - Communications
Bridgewater State University
Master of Business Administration -
Southern New Hampshire University